Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TOP1 | P11387 | 1/20 | 0.36 |
| ▸ | ACACA | Q13085 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 2/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.34 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | LTB4R | Q15722 | 3/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | HTR5A | P47898 | 1/20 | 0.33 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.33 |
| ▸ | HSD17B2 | P37059 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18200769 | 0.97 | ADORA2A (0.34) | TOP1ACACAALDH1A1MAPTDHODH | |
| SCHEMBL18346971 | 0.94 | ADORA2A (0.36) | TOP1ACACAALDH1A1MAPTDHODH | |
| SCHEMBL17034980 | 0.93 | DHODH (0.36) | TOP1ACACAALDH1A1DHODHADORA2A | |
| SCHEMBL18200991 | 0.93 | DHODH (0.36) | TOP1ACACADHODHCYP2C9ADORA2A | |
| SCHEMBL17034978 | 0.89 | DHODH (0.38) | TOP1ACACAALDH1A1DHODHADORA2A | |
| SCHEMBL17034970 | 0.87 | DHODH (0.37) | TOP1ALDH1A1MAPTDHODHADORA2A | |
| SCHEMBL18201313 | 0.87 | PDGFRB (0.41) | — | |
| SCHEMBL18201314 | 0.87 | TOP1 (0.35) | TOP1ACACADHODHADORA2ALTB4R | |
| SCHEMBL17034974 | 0.86 | DHODH (0.41) | TOP1ACACADHODHADORA2ALTB4R | |
| SCHEMBL17034887 | 0.86 | DHODH (0.41) | TOP1ACACADHODHADORA2ALTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9728731-B2 | Heterocyclic compound and organic light emitting device using same | HEESUNG MATERIAL LTD. (KR) | 2017-08-08 | — | — | US | disclosed |
| US-9728731-B2 | Heterocyclic compound and organic light emitting device using same | HEESUNG MATERIAL LTD. (KR) | 2017-08-08 | — | — | US | disclosed |
| US-20160380208-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | HEESUNG MATERIAL LTD. (KR) | 2016-12-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160380208-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME | NOTUM, DDT, CRY1 | TOP1 3101/4885ACACA 2979/4885ALDH1A1 85/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.